CurrentPartnering
Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.
Research Reports By CurrentPartnering
Found 197 publications
Global Molecular Diagnostics Partnering Terms and Agreements 2014 to2019
US$ 2,995.00
Jun, 2019 390 pages
Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2019
US$ 2,995.00
Jun, 2019 300 pages
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019
US$ 2,995.00
Jun, 2019 440 pages
Global Dental Partnering 2014-2019: Deal trends, players and financials
US$ 1,995.00
Jun, 2019 80 pages
Global Medical Device Partnering Terms and Agreements 2014-2019: Deal trends, players and financials
US$ 2,995.00
Jun, 2019 1000 pages
Global Immunology Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
Jun, 2019 400 pages
Global Hospital Care Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
Jun, 2019 400 pages
Global Gynecology Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
Jun, 2019 150 pages
Global Genetic Disorders Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
Jun, 2019 300 pages
Global Hematology Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
Jun, 2019 170 pages
Global Genitourinary Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
Jun, 2019 170 pages
Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 350 pages
Global Precision Medicine Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
May, 2019 550 pages
Global Cancer Vaccine Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 120 pages
Global Metabolic Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 500 pages
Global Biomarker Partnering Terms and Agreements 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 300 pages
Global In Vitro Diagnostics Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 250 pages
Global Oncology Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
May, 2019 2000 pages
Global Diagnostics Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
May, 2019 1000 pages
Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 210 pages
Global Antibiotics Partnering Terms and Agreements 2014 to 2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 150 pages
Global Musculoskeletal Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 300 pages
Global Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 650 pages
Global Cancer Diagnostics Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 400 pages
Global Companion Diagnostics Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 120 pages
Global Drug Delivery Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
May, 2019 570 pages
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 270 pages
Global Stem Cell Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 170 pages
Global Orphan Diseases Partnering 2014-2019: Deal trends, players and financials
US$ 2,995.00
May, 2019 130 pages
Global Infectious Diseases Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
May, 2019 750 pages
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019
US$ 2,995.00
Apr, 2019 500 pages
Global Gastrointestinal Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
Apr, 2019 250 pages
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019
US$ 2,995.00
Apr, 2019 600 pages
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019
US$ 2,995.00
Apr, 2019 2000 pages
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2019
US$ 2,995.00
Apr, 2019 250 pages
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2019
US$ 2,995.00
Apr, 2019 1700 pages
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019
US$ 2,995.00
Apr, 2019 300 pages
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2014-2019
US$ 2,995.00
Apr, 2019 200 pages
Global Central Nervous System Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
Apr, 2019 700 pages
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019
US$ 2,995.00
Apr, 2019 750 pages
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019
US$ 2,995.00
Apr, 2019 250 pages
Global Cardiovascular Partnering 2014-2019: Deal trends, players and financials
US$ 3,495.00
Apr, 2019 400 pages
